Meaning
Laboratory extractions performed under exaggerated conditions mobilize and characterize all non-bound chemical components contained within a solid plastic matrix. When evaluating medical devices or pharmaceutical contact materials, polymer extractables analysis identifies antioxidants and residual monomers that could leach into patient solutions. Exaggerated temperature and solvent conditions force potential migrants out of the polymer to establish a complete chemical inventory.
This characterization establishes the worst-case profile used to scope downstream leachable testing protocols.
Solvent Selection
Chemical dissolution studies select extraction media based on solvent polarity and swelling capability relative to the base polymer. During polymer extractables analysis, laboratories employ polar and non-polar solvents to isolate hydrophilic and lipophilic compounds. Solvents that swell the polymer matrix without dissolving the base resin maximize recovery of internal additives.
Inappropriate solvent selection causes resin dissolution, contaminating extract samples with heavy polymer chains that disrupt chromatographic columns.
Volatiles Profiling
Headspace gas chromatography isolates volatile degradation products trapped within moulded components. In polyolefin characterization, polymer extractables analysis measures low molecular weight oligomers. Elevated melt temperatures during injection moulding increase thermal cracking, raising volatile concentrations.
Controlling extruder residence time reduces volatile generation.
Threshold Screening
Toxicological risk assessments utilize chemical profiling data to establish safe exposure ceilings for medical device components. Applying polymer extractables analysis generates peak lists that are evaluated against analytical evaluation thresholds based on daily exposure limits. Unidentified peaks that breach safety thresholds require structure elucidation via high-resolution mass spectrometry.
Formulators refine additive packages to eliminate uncharacterized compounds, ensuring medical components achieve regulatory clearance before commercial release.